Trials / Conditions / Hepatitis B Infection

Hepatitis B Infection

19 registered clinical trials studyying Hepatitis B Infection.

Status	Trial	Sponsor	Phase
Completed	A Study to Evaluate Diagnostic Sensitivity and Specificity of iStatis HBsAg Test at the Point-Of-Care Sites NCT06368466	bioLytical Laboratories	N/A
Completed	Diagnostic Sensitivity and Specificity of iStatis HBsAg Test at the Point-Of-Care Site Settings NCT06368479	bioLytical Laboratories	N/A
Active Not Recruiting	Reducing Vertical Transmission of Hepatitis B in Africa NCT04704024	University of Alabama at Birmingham	Phase 3
Active Not Recruiting	Social-environmental, Psychosocial, Behavioral, Clinical and Biological Drivers of Disparities in Liver Diseas NCT05117541	Thomas Jefferson University	—
Terminated	Prophylactic Antiviral Therapy in Patients With Current or Past Hepatitis B Virus Infection Receiving Anti-Can NCT03887702	SWOG Cancer Research Network	Phase 3
Unknown	Hepatitis B Virus Infection After Liver Transplantation in Children NCT03865966	Qiu Li	—
Completed	Non Inferiority Trial of Locally Manufactured 'Hepa-B' Vaccine in Bangladesh. NCT03627507	International Centre for Diarrhoeal Disease Research, Bangladesh	Phase 2 / Phase 3
Unknown	Tenofovir Disoproxil Fumarate in Combination of Hepatitis B Vaccine for Preventing Hepatitis B Vertical Transm NCT03476083	New Discovery LLC	Phase 4
Unknown	HBV-associated Liver Transplant(LT) Patients by IV Injecting GC1102 NCT03519113	Green Cross Corporation	Phase 2 / Phase 3
Terminated	A Study of ALN-HBV in Healthy Adult Volunteers and Non-cirrhotic Patients With Chronic Hepatitis B Virus (HBV) NCT02826018	Alnylam Pharmaceuticals	Phase 1
Completed	A Phase 2 Study of GC1102 (Recombinant Hepatitis B Immunoglobulin) in HBV-related Liver Transplant Recipients NCT02304315	Green Cross Corporation	Phase 2
Completed	Navitoclax and Sorafenib Tosylate in Treating Patients With Relapsed or Refractory Solid Tumors NCT02143401	National Cancer Institute (NCI)	Phase 1
Completed	Evaluation of Paternal, Maternal and Obstetric Factors Leading to the Hepatitis B Immunization Failure in Hong NCT02443233	The University of Hong Kong	—
Completed	Widespread vs. Selective Screening for Hepatitis B Infection Prior to Chemotherapy NCT01970254	M.D. Anderson Cancer Center	—
Completed	Tenofovir in Late Pregnancy to Prevent Vertical Transmission of Hepatitis B Virus NCT01488526	New Discovery LLC	Phase 4
Completed	Nucleoside Analogue Prevent Vertical Transmission of Hepatitis B Virus NCT01788371	Hua Zhang	Phase 4
Completed	Effect of Entecavir in Blacks/African Americans and Hispanics With Chronic Hepatitis B Virus (HBV) Infection NCT00371150	Bristol-Myers Squibb	Phase 4
Completed	A Research Study to Test Safety, Tolerability, and Immunogenicity of a Recombinant Hepatitis B Vaccine Manufac NCT00489099	Merck Sharp & Dohme LLC	Phase 3
Completed	An Hepatitis B Vaccine Model for HIV Vaccine Trials in Drug Users NCT00841477	National Institute on Drug Abuse (NIDA)	Phase 3